ALPHA 1 Antitrypsin PCR Genotype (Anti-Trypsin)

Immunology


Description

AAT deficiency is an inherited autosomal co-dominant disorder in which over 100 alleles have been identified. It has an incidence of 1 in 2000-5000 individuals. The Z and S alleles are the most frequent AAT deficiency alleles [2,3]. Allele frequencies vary between different populations. Genetic counselling should be offered to all heterozygote individuals, Z carriers and their respective partners [1,3]. Phenotypic & genotypic analysis is mandatory for entry into the Antitrypsin Deficiency Assessment and Programme for Treatment ( ADAPT ) register.


Indications

Genotyping is used for the detection and/or confirmation of PI*S and PI*Z alleles of Human AAT gene.


Sample Type

2mL EDTA Whole blood or extracted DNA samples. Requests from outside Sheffield: Transport at ambient temperature via Royal Mail or Courier.


Reference Range

Qualitative assay. See report for comment.This assay is UKGTN registered.


Turnaround Time

Within 4 weeks


Testing Frequency

As required


External Notes

Intepret in conjuction with AAT quantitation and phenotyping.


References

PRU Handbook of Clinical Immunochemistry. 9th Edition. 2007. [Ref 1]James K Stoller, Lout. S Aboussouan. Alpha1-antitrypsin deficiency. Lancet. 2005. 365: 2225-2236. [Ref 2]M Luisetti and N Seersholm. Alpha 1-Antitrypsin deficiency.1: Epidemiology of alpha 1-antitrypsin deficiency. Thorax. 2004. 59:164-169. [Ref 3]


See Also

AAT Quantitation; AAT Phenotyping

Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.

Your contact for this test

team

Clare Del-Duca BSc (Hons) Biomedical Science, MSc Pathological Science

Laboratory Manager - Immunology and Protein Reference Unit

You are enquiring about

ALPHA 1 Antitrypsin PCR Genotype (Anti-Trypsin)